Quviviq (daridorexant) / Shionogi, Simcere, Nxera Pharma, Mochida, Syneos Health, Idorsia  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Quviviq (daridorexant) / Idorsia, Syneos Health, Nxera Pharma, Simcere
NCT06393504: Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

Active, not recruiting
N/A
2095
US
Daridorexant, QUVIVIQ, Non-orexin receptor antagonist insomnia medication, No insomnia medication
Idorsia Pharmaceuticals Ltd., Carelon Research
Insomnia Disorder
04/28
04/28
NCT06311864: Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada

Not yet recruiting
N/A
100
Canada
Daridorexant 50 mg, QUVIVIQ
PeriPharm, Idorsia Pharmaceuticals Ltd.
Insomnia
09/24
11/24

Download Options